AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients… Continue Reading
Articles
Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System
SUZHOU, China, Nov. 25, 2022 /PRNewswire/ — inQB8 Medical Technologies, LLC (inQB8), in Partnership with Peijia Medical Limited (Peijia, (9996.HK)), announced today that it… Continue Reading
Health Canada Authorizes POLIVY® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With Large B-Cell Lymphoma
MISSISSAUGA, ON, Nov. 24, 2022 /CNW/ – Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on November 14, 2022, Health Canada has… Continue Reading
Health Tech Firm CardieX Acquires Cardiovascular Sensor Company Blumio
ASX-listed health tech firm CardieX announced it acquired Silicon Valley-based Blumio, a developer of cardiovascular sensor algorithms and data analytics tools…. Continue Reading
FDA Grants Priority Review to Takeda’s Dengue Vaccine
The FDA granted priority review to Takeda’s Biologics License Application for TAK-003, a dengue vaccine candidate. The vaccine to date is only approved… Continue Reading
Arvinas’ Experimental Breast Cancer Drug Fails to Impress Analysts
Late Monday, Arvinas Inc. was forced to divulge the contents of its upcoming breast cancer data presentation, slated for the 2022… Continue Reading
Novartis and MMV Move to Pivotal Study with New Class of Drug for Malaria
Partners Novartis and Medicines for Malaria Venture (MMV) are moving into Phase III for a combination treatment targeting the rise of artemisinin-resistant Malaria infection, the companies… Continue Reading
Oxurion Further Improves THR-149 Patent Position
Leuven, BELGIUM, Boston, MA, US – November 23, 2022 –5:00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care… Continue Reading
Provider Burnout Has Leveled Out in 2022; Staffing Shortages Rises, KLAS Reports
What You Should Know: Value-based care (VBC) has been established as a priority among healthcare organizations and payers as participants… Continue Reading
Site Enablement Platforms Can Accelerate Clinical Trials by 6 Weeks and Reduce Costs by Over $1M
What You Should Know: – Florence HealthcareTM, a clinical research technology company headquartered in Atlanta, Georgia, recently announced the completion… Continue Reading